BARDA’s ASSURE Program to Advance Next-Generation Immune Assays
RPPV-26-07-ASSURE-Amendment-2 The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR), has released a new opportunity under the Rapid Response Partnership Vehicle (RRPV): the Assay Development for Superior Understanding of Response and Efficacy (ASSURE) program. Designed to strengthen national health security, ASSURE seeks to accelerate the development […]
BARDA’s ASSURE Program to Advance Next-Generation Immune Assays Read More »